Navigation Links
Rivaroxaban in Medical News

New Anticoagulant Pill Works Well in Trial

... 17 (HealthDay News) -- The new anti-clotting pill rivaroxaban (Xarelto) lowers the risk of stroke, heart attack ...suffer from unstable angina, a new trial shows. rivaroxaban is a pill that blocks factor Xa, which is involved... these observations, a phase III study of low-dose rivaroxaban as adjunctive therapy in these patients is underwa...

FDA Panel Backs New Anti-Clotting Drug

... rivaroxaban could replace heparin after hip- or knee-replaceme...e benefits of the experimental blood-thinning drug rivaroxaban outweigh its risks, a U.S. Food and Drug Administration advisory panel said Thursday. rivaroxaban (Xarelto) could be one of the long-sought alternat...

Research highlights new approaches to prevent blood clots

...rates of secondary endpoints. Once-Daily Oral rivaroxaban Compared With Subcutaneous Enoxaparin Every 12 Hou...ous research that demonstrated that post-operative rivaroxaban was more effective than pre-operative enoxaparin i... were randomized to receive either once-daily oral rivaroxaban (10 mg) starting six to eight hours after surgery ...

Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data

...ed on a study of a new oral anti-clotting agent -- rivaroxaban -- designed to identify doses that would be safe t... Earlier studies had shown the experimental drug rivaroxaban effective at keeping blood clots from forming in t...ndomized to twice a day doses of 2.5 mg or 5 mg of rivaroxaban for six months is expected to begin in December 20...

Speed Not Always of the Essence With Heart Cases in ER

...ble angina). The study was the first to look at the effects of the drug in the arteries. Existing drugs target the platelets in the bloodstream. rivaroxaban targets a different part of the clotting process, called Factor X, said principal investigator Dr. Michael Gibson, chief of clinical research in cardi...

Oral Drug Helps Prevent Clotting After Hip Replacement

... Daily dose of rivaroxaban cut risk of venous thromboembolism, study finds ... (HealthDay News) -- Extended use of the oral drug rivaroxaban helps prevent potentially fatal blood clots after ...nstitute compared the new oral antithrombotic drug rivaroxaban (Xarelto) with enoxaparin in the treatment of hip ...

Rivaroxaban phase III pivotal data presented at EFORT annual meeting

...ent (TKR) surgery. The head-to-head study compared rivaroxaban with the U.S.-approved dosing regimen for enoxapar...ociations of Orthopaedics & Traumatology (EFORT). rivaroxaban is being jointly developed by Johnson & Johnson Ph...ayer HealthCare AG. The RECORD4 data show that rivaroxaban (10mg once-daily) provided TKR surgery patients a ...

Research Highlights New Approaches to Management of Blood Clotting and Bleeding Disorders

...red dose of an oral, direct Factor Xa inhibitor -- rivaroxaban -- for extended prevention of blood clotting after... III trial studied the efficacy and safety of oral rivaroxaban in comparison to subcutaneous enoxaparin to preven...l of 4,541 randomized patients who either received rivaroxaban 10 mg beginning six to eight hours after surgery a...
Rivaroxaban in Medical Technology

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

GENEVA--(BUSINESS WIRE)--Jul 8, 2007 - Late-breaking Phase III clinical trial data presented today at the XXI International Society on Thrombosis and Haemostasis (ISTH) Congress demonstrate that once-daily rivaroxaban achieved superior efficacy in the prevention of venous thromboembolism (VTE) in p...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Rivaroxaban, a New Oral, Once-Daily Direct Factor Xa Inhibitor, Shows a Significant Reduction in Deep Vein Thrombosis and Pulmonary Embolism Compared with Enoxaparin with Similarly Low Bleeding Rates GENEVA, July 8, 2007 - Late-breaking Phase III clinical trial data presented today at the XXI In...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... of secondary endpoints. Once-Daily Oral rivaroxaban Com p ared With Subcutaneous Enoxaparin Ev...ous research that demonstrated that post-operative rivaroxaban was more effective than pre-operative enoxaparin i... were randomized to receive either once-daily oral rivaroxaban (10 mg) starting six to eight hours after surgery ...
Other Tags
(Date:9/20/2014)... Traditionally dentists have advised their patients against ... Dentistry is re-visiting that advice and changing his stance ... and wine have on oral health. “There’s good news and ... may be beneficial in protecting against gum disease, and red ... on coffee was from the September 2014 issue of ...
(Date:9/20/2014)... 20, 2014 QueenBeeTickets.com is ready to ... tour performances. She will visit many cities in North ... the 16th of April. , Click Here ... tickets at QueenBeeTickets.com. , The star’s fans are not ... their favorite young singer in a live performance. Ariana ...
(Date:9/20/2014)... “Motherhood is a wonderful gift and a huge responsibility,” says ... , “We know that you want to care for your ... to do as well.” , The article explains to new ... Family Physicians who practice obstetrics while pregnant, during delivery, and ... learn more about Community Health Center of Snohomish County and ...
(Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing tactic ... patients with prescription drug coverage, may now be infiltrating ... from the Department of Health and Human Services ... prohibit suppliers from offering side-payments to increase sales of ... The report highlights that two recent surveys, including one ...
(Date:9/19/2014)... September 19, 2014 On September 16, ... the Platinum PR and Top Places to Work in ... York City. Camino received honorable mentions in two categories ... for its work elevating Latina voices in the media. ... and be a part of its efforts to improve ...
Breaking Medicine News(10 mins):Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News:Camino Public Relations Honored for Raising Latina Voices in National Health Care, Immigration Debates 2
(Date:9/18/2014)... found clownfish larvae can swim up to 400 kilometres in ... cope with environmental change. , Clownfish spend their entire adult ... babies they must wander the open ocean, says study co-author, ... Coral Reef Studies (Coral CoE) at James Cook University. , ... now we,ve been given a rare glimpse into how far ...
(Date:9/17/2014)... UCLA atmospheric scientists were instrumental in the creation of ... tool to classify the fire threat potential of the ... a spark into an inferno. The index was introduced ... with UCLA and San Diego Gas and Electric. , ... to "extreme" that will be used to help fire ...
(Date:9/17/2014)... EC-FP5 four-year project, delivering its first release in 2004. ... in several EC projects, as a part of the ... BON), to increase the general awareness of the work ... dissemination of the Fauna Europaea results, the ... e-Publishing tools to prepare data papers for all 56 ...
Breaking Biology News(10 mins):Nemo's epic journey to find a new home 2UCLA scientists play key role in developing new Santa Ana Wildfire Threat Index 2Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2
Other Contents